Addiction Coping and Recovery Overcoming Addiction Controlling Alcohol Cravings With Medication By Buddy T Buddy T Facebook Twitter Buddy T is an anonymous writer and founding member of the Online Al-Anon Outreach Committee with decades of experience writing about alcoholism. Learn about our editorial process Updated on February 16, 2022 Medically reviewed Verywell Mind articles are reviewed by board-certified physicians and mental healthcare professionals. Medical Reviewers confirm the content is thorough and accurate, reflecting the latest evidence-based research. Content is reviewed before publication and upon substantial updates. Learn more. by Amy Morin, LCSW, Editor-in-Chief Print Jacobs Stock Photography/DigitalVision/Getty Table of Contents View All Table of Contents FDA-Approved Medications Medications Under Investigation Alternatives to Medications People who have become alcohol dependent often experience withdrawal symptoms and cravings when they try to stop drinking, and these cravings can pose problems for those trying to quit. The good news, however, is that there are medications that may help manage these alcohol cravings and assist someone in their recovery from alcohol use disorder (AUD). Here, we review medications that are FDA-approved, those under investigation, as well as alternatives to medication that can also help manage cravings. In a 2019 study published in Alcohol and Alcoholism, elevated cravings were associated with post-addiction treatment relapse in a group diagnosed with alcohol dependence. Approved Medications for Alcohol Cravings There are three medications that have been FDA-approved for the treatment of AUD, and two of them may help manage alcohol cravings. Vivitrol (Naltrexone) Vivitrol is a once-monthly injection that works by blocking the high in the brain that people experience when they drink alcohol. Naltrexone is also available as a tablet in the generic form. By blocking the pleasure the person receives from alcohol and the reward feedback loop in the brain, naltrexone eventually reduces cravings. Acamprosate Acamprosate, previously marketed as Campral in the United States, reduces the physical distress and emotional discomfort people usually experience when they quit drinking. How it works to lessen the craving for alcohol is not completely understood, but researchers believe that it helps restore a chemical imbalance in the brain's reward system that is altered by long-term alcohol abuse. Acamprosate does not help someone quit drinking. It is prescribed (usually three time-released pills a day) for those who have already stopped drinking alcohol. Because the side effects are mild and well-tolerated, it is usually prescribed for up to 12 months following alcohol abstinence. Antabuse (Disulfiram) Antabuse, the brand name for disulfiram, does not target cravings. It works by causing a severe adverse reaction when someone taking the medication consumes alcohol, which includes: FlushingNauseaVomitingHeadachesPalpitations Because reactions can be severe, it might be saved for use in high-risk patients, or when you are going into a high-risk situation such as a party where there will be alcohol. Medications Under Investigation In addition to FDA-approved medications , there are also those which are prescribed off-label to treat AUD, those being studied for this use, and others that have been approved to treat alcohol dependence outside of the United States. Topamax (Topiramate): Topamax is an anti-epileptic medication that has shown promise in trials similar to naltrexone. Physicians may prescribe it off-label for alcohol dependence. Neurontin (Gabapentin): Neurontin is also an anti-epileptic drug approved to treat seizures and postherpetic neuralgia, a type of pain associated with shingles. Some research has shown it may be effective in helping to reduce cravings. Zofran (Ondansetron): Zofran is indicated for nausea and vomiting in people being treated for cancer. In some older research, it was associated with reduced cravings in young adults with early AUD when combined with cognitive behavioral therapy (CBT). Selincro (Nalmefene): Selincro has been approved for use in Australia and Europe to help reduce drinking. Some have noted controversy around this approval. It can be taken on an as-needed basis, as in before a high-risk situation, and has been associated with a reduction in heavy drinking days. However, some research on its efficacy has been mixed. Baclofen: Baclofen, a muscle relaxant, is available in branded forms Ozobax, Lioresal, Gablofen and available as a pill, injectable, and an oral solution in the United States. It has been approved to treat AUD in France. The results on how well it treats AUD have been mixed. Selective serotonin reuptake inhibitors (SSRIs): The American Psychiatric Association (APA) doesn't recommend antidepressants for AUD unless there is another disorder present they would treat. In one small double-blind, placebo controlled study from 2019, a group of 10 people with alcohol dependency who received citalopram had less cue-induced craving for alcohol. Preventing Alcohol Cravings Alternatives to Medications In addition, there is more than just medication that may help with alcohol cravings. The following could be used with or without medication. Cognitive Behavioral Therapy (CBT) CBT is a form of psychotherapy, or talk therapy, used in the treatment of substance use disorders, including AUD. CBT works to help someone reframe their thoughts and change their actions. It can be useful in addressing cravings as it can help someone come up with coping mechanisms for when they occur. Support Groups According to the National Institute on Alcohol Abuse and Alcoholism, participating in a mutual-help group like Alcoholics Anonymous (AA) or another 12-step program can provide even more support when combined with other treatment. In addition, being around a new community that encourages sobriety may be helpful to diminish external cues for alcohol cravings. A small survey and small study found less self-reported cravings in AA members who had said they'd had a “spiritual awakening” (no cravings the week before) and in a small group who prayed (in the moment after viewing craving inducing-images). At the same time, a review from 2017 points to AA’s benefits primarily coming from therapeutic factors that mirror those found in other treatment—those that are social, cognitive, and affective. As the review points out, however, this needs further study. Can Cognitive Behavioral Therapy (CBT) Treat Addiction? If you or a loved one are struggling with substance use or addiction, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-4357 for information on support and treatment facilities in your area. For more mental health resources, see our National Helpline Database. 28 Sources Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Seo D, Sinha R. The neurobiology of alcohol craving and relapse. Handb Clin Neurol. 2014;125:355-368. doi:10.1016/B978-0-444-62619-6.00021-5 Stohs ME, Schneekloth TD, Geske JR, Biernacka JM, Karpyak VM. Alcohol craving predicts relapse after residential addiction treatment. Alcohol and Alcoholism. 2019;54(2):167-172. doi:10.1093/alcalc/agy093 Rutkofsky IH, Fisher KA, Alvarez Villalba CL, Neuhut S. Gabapentin for post-hospitalization alcohol relapse prevention; should gabapentin be considered for FDA approval in the treatment of alcohol use disorder? : A case presentation and literature review. Cureus. 2020;12(6):e8931. doi:10.7759/cureus.8931 Patel AK, Balasanova AA. Treatment of alcohol use disorder. JAMA. 2021;325(6):596. doi:10.1001/jama.2020.2012 Canidate SS, Carnaby GD, Cook CL, Cook RL. A systematic review of naltrexone for attenuating alcohol consumption in women with alcohol use disorders (AUD). Alcohol Clin Exp Res. 2017;41(3):466-472. doi:10.1111/acer.13313 Salib A-MN, Ho AL, Sussman ES, Pendharkar AV, Halpern CH. Neuromodulatory treatments for alcohol use disorder: A review. Brain Sciences. 2018;8(6):95. doi:10.3390/brainsci8060095 Substance Abuse and Mental Health Services Administration. MAT medications, counseling, and related conditions. Plosker GL. Acamprosate: A review of its use in alcohol dependence. Drugs. 2015;75(11):1255-68. doi:10.1007/s40265-015-0423-9 Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis. PLoS ONE. 2014;9(2):e87366. doi:10.1371/journal.pone.0087366 Guglielmo R, Martinotti G, Quatrale M, et al. Topiramate in alcohol use disorders: Review and update. CNS Drugs. 2015;29(5):383-95. doi:10.1007/s40263-015-0244-0 Food and Drug Administration. Neurontin highlights of prescribing information. Food and Drug Administration. Zofran highlights of prescribing information. Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M. Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology. 2002;160(4):408-413. doi:10.1007/s00213-002-1002-9 Morley KC, Perry CJ, Watt J, et al. New approved and emerging pharmacological approaches to alcohol use disorder: A review of clinical studies. Expert Opinion on Pharmacotherapy. 2021;0(0):1-13. doi:10.1080/14656566.2021.1892641 Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F. Risks and benefits of nalmefene in the treatment of adult alcohol dependence: A systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials. PLOS Medicine. 2015;12(12):e1001924. doi:10.1371/journal.pmed.1001924 Kim Y, Hack LM, Ahn ES, Kim J. Practical outpatient pharmacotherapy for alcohol use disorder. Drugs Context. 2018;7. doi:10.7573/dic.212308 Food and Drug Administration. FDA Approved Drugs - baclofen. Shen WW. Anticraving therapy for alcohol use disorder: A clinical review. Neuropsychopharmacol Rep. 2018;38(3):105-116. doi:10.1002/npr2.12028 American Psychiatric Association. Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder. American Psychiatric Association Publishing; 2018. Zorick T, Okita K, Mandelkern MA, London ED, Brody AL. Effects of citalopram on cue-induced alcohol craving and thalamic d2/3 dopamine receptor availability. International Journal of Neuropsychopharmacology. 2019;22(4):286-291. doi:10.1093/ijnp/pyz010 Department of Health and Human Services. Medication for the treatment of alcohol use disorder: A brief guide. Magill M, Ray L, Kiluk B, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093-1105. doi:10.1037/ccp0000447 National Institute for Drug Abuse. Cognitive-behavioral therapy (alcohol, marijuana, cocaine, methamphetamine, nicotine). National Institute on Alcohol Abuse and Alcoholism. Treatment for alcohol problems: Finding and getting help. Donovan DM, Ingalsbe MH, Benbow J, Daley DC. 12-step interventions and mutual support programs for substance use disorders: An overview. Soc Work Public Health. 2013;28(0):313-332. doi:10.1080/19371918.2013.774663 Dermatis H, Galanter M. The role of twelve-step-related spirituality in addiction recovery. J Relig Health. 2016;55(2):510-521. doi:10.1007/s10943-015-0019-4 Galanter M, Josipovic Z, Dermatis H, Weber J, Millard MA. An initial fMRI study on neural correlates of prayer in members of Alcoholics Anonymous. The American Journal of Drug and Alcohol Abuse. 2017;43(1):44-54. doi:10.3109/00952990.2016.1141912 Kelly JF. Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction. 2017;112(6):929-936. doi:10.1111/add.13590 Additional Reading Donovan DM, Anton RF, Miller WR, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The combine study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs. 2008;69(1):5-13. doi:10.15288/jsad.2008.69.5 UpToDate. Pharmacotherapy for alcohol use disorder. By Buddy T Buddy T is an anonymous writer and founding member of the Online Al-Anon Outreach Committee with decades of experience writing about alcoholism. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit Get Treatment for Addiction Advertiser Disclosure × The offers that appear in this table are from partnerships from which Verywell Mind receives compensation.